Aspira Women's Health Inc.
AWH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.02 | 0.04 | 0.13 | -0.10 |
| FCF Yield | -121.93% | -42.25% | -78.45% | -14.01% |
| EV / EBITDA | -0.71 | -2.30 | -0.99 | -5.07 |
| Quality | ||||
| ROIC | -1,864.60% | -881.76% | -237.88% | -95.09% |
| Gross Margin | 59.67% | 57.48% | 52.77% | 44.95% |
| Cash Conversion Ratio | 0.93 | 0.95 | 1.04 | 0.87 |
| Growth | ||||
| Revenue 3-Year CAGR | 3.91% | 10.35% | 20.73% | 14.50% |
| Free Cash Flow Growth | 23.67% | 49.14% | -13.49% | -81.15% |
| Safety | ||||
| Net Debt / EBITDA | -0.10 | -0.02 | 0.31 | 1.02 |
| Interest Coverage | 493.27 | 0.00 | 0.00 | -679.06 |
| Efficiency | ||||
| Inventory Turnover | 11.36 | 17.15 | 12.23 | 21.55 |
| Cash Conversion Cycle | -142.70 | -38.80 | 2.17 | -74.13 |